DBL™ Pethidine Hydrochloride Injection New Zealand - English - Medsafe (Medicines Safety Authority)

dbl™ pethidine hydrochloride injection

pfizer new zealand limited - pethidine hydrochloride 50 mg/ml; pethidine hydrochloride 50 mg/ml - solution for injection - 50 mg/ml - active: pethidine hydrochloride 50 mg/ml excipient: water for injection active: pethidine hydrochloride 50 mg/ml excipient: sodium hydroxide water for injection - dbl pethidine hydrochloride injection is indicated for administration as an anaesthetic adjunct and for obstetric analgesia. dbl pethidine hydrochloride injection is also indicated for the short-term (24 to 36 hours) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. it can be given via the following routes of administration – intramuscular (im), subcutaneous (sc), slow intravenous (iv) bolus injection, intravenous infusion and patient-controlled analgesia (pca).

DBL PETHIDINE HYDROCHLORIDE 100mg/2mL Injection Australia - English - Department of Health (Therapeutic Goods Administration)

dbl pethidine hydrochloride 100mg/2ml injection

pfizer australia pty ltd - pethidine hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - dbl pethidine hydrochloride injection is indicated for the short term (24 to 36 hours) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. it can be given via the following routes of administration: intramuscular, subcutaneous, slow intravenous bolus injection, intravenous infusion and patient controlled analgesia (pca).,dbl pethidine hydrochloride injection is indicated for administration as an anaesthetic adjunct and for obstetric analgesia.

DBL PETHIDINE HYDROCHLORIDE 50mg/1mL Injection Australia - English - Department of Health (Therapeutic Goods Administration)

dbl pethidine hydrochloride 50mg/1ml injection

pfizer australia pty ltd - pethidine hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - dbl pethidine hydrochloride injection is indicated for the short term (24 to 36 hours) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. it can be given via the following routes of administration: intramuscular, subcutaneous, slow intravenous bolus injection, intravenous infusion and patient controlled analgesia (pca).,dbl pethidine hydrochloride injection is indicated for administration as an anaesthetic adjunct and for obstetric analgesia.

Pethidine Hydrochloride 50mg/ml Solution for injection (1ml) Malta - English - Medicines Authority

pethidine hydrochloride 50mg/ml solution for injection (1ml)

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - pethidine hydrochloride - solution for injection - pethidine hydrochloride 50 mg/ml - analgesics

Pethidine Hydrochloride 50mg/ml Solution for injection (2ml) Malta - English - Medicines Authority

pethidine hydrochloride 50mg/ml solution for injection (2ml)

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - pethidine hydrochloride - solution for injection - pethidine hydrochloride 50 mg/ml - analgesics

PETHIDINE JUNO pethidine injection BP 100mg/2mL ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

pethidine juno pethidine injection bp 100mg/2ml ampoule

juno pharmaceuticals pty ltd - pethidine hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 18 may 2020: 1. the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. 2. pre-operative medication. 3. analgesic adjunct in general anaesthesia. 4. obstetric analgesia.

Pethidine Hydrochloride (Douglas) New Zealand - English - Medsafe (Medicines Safety Authority)

pethidine hydrochloride (douglas)

douglas pharmaceuticals limited - pethidine hydrochloride 100mg;   - tablet - 100 mg - active: pethidine hydrochloride 100mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate

Pethidine Hydrochloride (Douglas) New Zealand - English - Medsafe (Medicines Safety Authority)

pethidine hydrochloride (douglas)

douglas pharmaceuticals limited - pethidine hydrochloride 50mg;   - tablet - 50 mg - active: pethidine hydrochloride 50mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate

Pethidine Hydrochloride 50mg/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

pethidine hydrochloride 50mg/ml solution for injection

mercury pharmaceuticals (ireland) ltd - pethidine hydrochloride - solution for injection - 50 milligram(s)/millilitre - phenylpiperidine derivatives; pethidine

Pethidine Hydrochloride 50 mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

pethidine hydrochloride 50 mg/ml solution for injection

accord healthcare ireland ltd. - pethidine hydrochloride - solution for injection - 50 milligram(s)/millilitre - phenylpiperidine derivatives; pethidine